Raymond Wagenknecht
Managing Patent Attorney
(858) 587-2510 ext. 201

View Raymond Wagenknecht's profile on LinkedIn


patent attorney

Ray has prosecuted over 100 US Patents in technologies ranging from medical devices and treatments - to - electronic monitoring of cells - to - DNA and RNA analytic methods - to - protection against electromagnetic radiation and more. His patent practice includes patent counseling; preparation and prosecution of patent applications; patent porfolio management and audits; due diligence; freedom to operate analysis; non-infringement opinions; and patent litigation services.

Ray's trademark practice includes trademark counseling and registration; trademark oppositions, and trademark cancellations.

Ray is also an accomplished researcher. He is a contributing author on a number of peer-reviewed scientific publications in the field of immunology and drug discovery. Ray was formerly a researcher within the Department of Medicine at the University of California, San Diego (UCSD) and at a San Diego-based start-up biotechnology company.

Ray received a Bachelor of Science degree in Molecular Biology from the University of California, San Diego (UCSD) (1995) and a Juris Doctorate at the University of San Diego, School of Law (2002), where he was elected Vice President of the Science and Technology Law Society.

Bar & Admissions

  • State of California
  • United States Patent and Trademark Office (USPTO)

  • US District Court, Southern District of California
  • US District Court, Central District of California
  • US Court of Appeals for the Federal Circuit (Washington, DC)

Representative Patents

  • US 8,344,742 - Real time electronic cell sensing system and applications for cytotoxicity profiling and compound assays
  • US 8,329,114 - Devices and methods for sampling biological fluids
  • US 8,283,169 - Differential Gradient Separation of Cells
  • US 8,142,444 - Circumcision clamp and surgical kit
  • US 8,058,296 - Treatment and prevention of deleterious effects associated with alcohol consumption
  • US 8,044,376 - Devices and methods for protection against exposure to electromagnetic radiation
  • US 7,816,080 - Identifying organisms by detecting intronic nucleic acid or encoded proteins
  • US 7,780,915 - Fecal sample test device and methods of use
  • US 7,741,539 - Transformed plant cell expressing five mammalian proteins involved in sialylation and a protein involved in galactosylation
  • US 7,741,028 - Methods of identifying genetic markers in the human cystic fibrosis transmembrane conductance regulator (CFTR) gene

Scientific Publications

  • A B Cell Superantigen-induced Persistent 'Hole' in the B-1 Repertoire
    G.J. Silverman, S. Cary, D. Dwyer, L. Luo, R. Wagenknecht and V.E. Curtiss.
    J. Exp. Med., 2000 Jul 3;192(1):87-98.
  • Characterization of Superantigen-Induced Clonal Deletion with a Novel Clan III-Restricted Avian Monoclonal Antibody: Exploiting Evolutionary Distance to Create Antibodies Specific for a Conserved VH Region Surface
    Cary SP, Lee J, Wagenknecht R, Silverman GJ
    J. Immunol., 2000 May 1;164(9):4730-41
  • A B-Cell Superantigen That Targets B-1 Lymphocytes"
    Silverman GJ, Cary S, Graille M, Curtiss VE, Wagenknecht R, Luo L, Dwyer D, Goodyear C, Corper AL, Stura EA, Charbonnier JB
    Curr Top Microbiol Immunol. 2000;252:251-63
  • Improved two-dimensional gel electrophoresis representation of serum proteins using ProtoClearTM
    Lollo BA, Harvey S, Liao J, Stevens AC, Wagenknecht R, Sayen R, Whaley J, Sajjadi FG.
    Electrophoresis, 1999 Apr-May;20:854-9
  • In Vivo Consequences of a B-Cell Superantigen Immunization”
    Gregg J. Silverman, Jayakar Nayak, Raymond Wagenknecht, Klaus Warnatz.
    Ann. N.Y. Acad. Sci., 1997 Apr 5;815:105-110